IEEE VIS 2024 Content: DITTO: A Visual Digital Twin for Interventions and Temporal Treatment Outcomes in Head and Neck Cancer

DITTO: A Visual Digital Twin for Interventions and Temporal Treatment Outcomes in Head and Neck Cancer

Andrew Wentzel - University of Illinois at Chicago, Chicago, United States

Serageldin Attia - University of Houston, Houston, United States

Xinhua Zhang - University of Illinois Chicago, Chicago, United States

Guadalupe Canahuate - University of Iowa, Iowa City, United States

Clifton David Fuller - University of Texas, Houston, United States

G. Elisabeta Marai - University of Illinois at Chicago, Chicago, United States

Room: Bayshore V

2024-10-17T18:45:00ZGMT-0600Change your timezone on the schedule page
2024-10-17T18:45:00Z
Exemplar figure, described by caption below
Overview of DITTO. (A) Input panel to alter model parameters and input patient features. (B) Temporal outcome risk plots for the patient based on different models and treatment groups. (C) Treatment recommendation based on the twin model and similar patients. (D) Auxiliary data panel, currently showing a waterfall plot of how each feature cumulatively contributes to the model decision.
Fast forward
Full Video
Keywords

Medicine; Machine Learning; Application Domains; High Dimensional data; Spatial Data; Activity Centered Design

Abstract

Digital twin models are of high interest to Head and Neck Cancer (HNC) oncologists, who have to navigate a series of complex treatment decisions that weigh the efficacy of tumor control against toxicity and mortality risks. Evaluating individual risk profiles necessitates a deeper understanding of the interplay between different factors such as patient health, spatial tumor location and spread, and risk of subsequent toxicities that can not be adequately captured through simple heuristics. To support clinicians in better understanding tradeoffs when deciding on treatment courses, we developed DITTO, a digital-twin and visual computing system that allows clinicians to analyze detailed risk profiles for each patient, and decide on a treatment plan. DITTO relies on a sequential Deep Reinforcement Learning digital twin (DT) to deliver personalized risk of both long-term and short-term disease outcome and toxicity risk for HNC patients. Based on a participatory collaborative design alongside oncologists, we also implement several visual explainability methods to promote clinical trust and encourage healthy skepticism when using our system. We evaluate the efficacy of DITTO through quantitative evaluation of performance and case studies with qualitative feedback. Finally, we discuss design lessons for developing clinical visual XAI applications for clinical end users.